Medical Risk Managers

MRM offices are closed in recognition of President's Day.

Yesterday evening marked the beginning of Hanukkah. Wishing everyone celebrating a joyful and healthy Hanukkah!

he gene therapy approvals keep on coming with BioMarin’s Roctavian receiving approval today. The therapy could reduce or free hemophilia A patients from "bleeds" for years.

https://prn.to/3PBWLiJ

U.S. Food and Drug Administration Approves BioMarin's ROCTAVIAN™ (valoctocogene roxaparvovec-rvox), the First and Only Gene Therapy for Adults with Severe Hemophilia A /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today...